
Sign up to save your podcasts
Or


This week the EU unveiled its plan to rein in big tech—the draft laws target the American giants, but European firms may not benefit much. Also, how a failed study has revealed a promising new gene-therapy treatment for blindness. And, which science stories were overlooked in a year dominated by covid-19? Kenneth Cukier hosts
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.
By The Economist4.8
581581 ratings
This week the EU unveiled its plan to rein in big tech—the draft laws target the American giants, but European firms may not benefit much. Also, how a failed study has revealed a promising new gene-therapy treatment for blindness. And, which science stories were overlooked in a year dominated by covid-19? Kenneth Cukier hosts
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.

4,161 Listeners

920 Listeners

365 Listeners

213 Listeners

99 Listeners

107 Listeners

649 Listeners

227 Listeners

2,554 Listeners

46 Listeners

1,080 Listeners

1,412 Listeners

143 Listeners

115 Listeners

102 Listeners

37 Listeners

449 Listeners

892 Listeners

376 Listeners

498 Listeners

79 Listeners

181 Listeners

149 Listeners

71 Listeners

100 Listeners

263 Listeners